TJ 114

Drug Profile

TJ 114

Alternative Names: Sairei-to; Saireto

Latest Information Update: 31 May 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source; Tsumura
  • Class Antipsoriatics; Antirheumatics; Phytotherapies
  • Mechanism of Action Antioxidants; Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Crohn's disease; Ulcerative colitis
  • No development reported Diabetic nephropathies; Genitourinary disorders; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 31 May 2003 No development reported - Clinical-Phase-Unknown for Genitourinary disorders in Japan (unspecified route)
  • 09 May 2003 No development reported - Clinical-Phase-Unknown for Diabetic nephropathies in Japan (PO)
  • 25 Mar 1999 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top